Atypical haemolytic uraemic syndrome (aHUS) - eculizumab extended initial PBS authority application Supporting information form (PB175)

Use this form for a patient applying for extended initial treatment with Pharmaceutical Benefit Scheme (PBS) subsidised eculizumab for aHUS.